cetylpyridinium chloride anhydrous has been researched along with leuprolide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailey, JN; Bowers, CY; Erickson, D; Hudson, SB; Reynolds, GA; Veldhuis, JD | 1 |
Bowers, CY; Miles, JM; Norman, C; Veldhuis, JD | 1 |
2 trial(s) available for cetylpyridinium chloride anhydrous and leuprolide
Article | Year |
---|---|
Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women.
Topics: Adolescent; Adult; Aged; Aging; Estradiol; Female; Gonadotropin-Releasing Hormone; Health; Human Growth Hormone; Humans; Intra-Abdominal Fat; Leuprolide; Middle Aged; Placebos; Pulsatile Flow; Young Adult | 2009 |
Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men.
Topics: Age Factors; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Ghrelin; Gonadal Steroid Hormones; Growth Hormone-Releasing Hormone; Health; Human Growth Hormone; Humans; Infusions, Intravenous; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Leuprolide; Male; Middle Aged; Placebos; Pulsatile Flow; Somatostatin | 2012 |